Stocks In News, Share Market News, Quarterly Results News

11 November 2022

FII & DII DATA 

FII Net  BUY - 3,958.23cr
DII Net BUY - 615.54cr

14 November 2022

Today Results 

Aarti Ind
Abbott India
Aditya Vision
Advait Infratec
AFL
Agarwal Ind
AGI Infra
Ahluwalia
AIA Engineering
Alicon Castallo
Alfred Herbert
Apollo Tyres
Arman Financial
Ashiana Housing
Asian Hotel (E)
Assam
Balkrishna Ind
Balmer Invest
BCL Industries
Bharat Bijlee
Bharat Agri
Biocon
Brooks Labs
Cosmo First
Cosco India
DFM Foods
Dilip Buildcon
Emami Paper
Dish TV
FDC
Eureka Forbes
Cupid
Godrej Ind
GE Power India
Grasim
Goodyear
Hariom Pipe
Hi-Tech Pipes
Hinduja Global
HINDWAREAP
HUDCO
IOL Chemicals
IST Ltd
Jindal PolyFilm
Jindal Photo
Kama Holdings
Kalyani Forge
Jyothy Labs
Kaveri Seed
Lux Industries
Linde India
Orchid Pharma
Parag Milk Food
Polyplex Corp
PTC Industries
Radico Khaitan
Repro India
RPSG VENTURES
Rubfila Intl
Samrat Pharma
Shree Pushkar
Sharda Motor
Suprajit Eng
Swan Energy.
Tide Water Oil
Titan Biotech
Uflex
Vesuvius India
Varroc Engineer
Vindhya Telelins
Welspun Enter

Stocks In News 
Quarterly Results News 

LIC

The life insurance company clocked a 27 percent year-on-year growth in net premium at Rs 1.32 lakh crore for the quarter ended September FY23. The net profit for the quarter at Rs 15,952 crore jumped 11-fold over Rs 1,434 crore last year, partly driven by incomes. The company's other income stood at Rs 6,795 crore as against Rs 46 crore a year back for the quarter, including refund of income tax.



MOIL

The state-run manganese ore mining company has recorded a 54.7% year-on-year fall in profit at Rs 27.3 crore for the quarter ended September FY23 impacted by lower topline as well as weak operating performance. Revenue for the quarter declined by 34.3% to Rs 236 crore and EBITDA tanked 59% to Rs 33 crore with margin falling by 12 percentage points compared to year-ago period.


BHEL 

The power equipment manufacturer has recorded standalone profit of Rs 10.3 crore for the quarter ended September FY23 against loss of Rs 67.5 crore in same period last year, largely due to tax write-back and higher other income. Standalone revenue grew by 1.8% YoY to Rs 5,202.6 crore for the quarter, and standalone EBITDA loss widened to Rs 243.9 crore from Rs 29 crore on-year basis.



Zee Entertainment Enterprises 

The media and entertainment company reported a 58% year-on-year decline in profit at Rs 112.8 crore for the September FY23 quarter, dented by weak operating performance and muted topline growth. Revenue for the quarter at Rs 2,028.4 crore grew by 2.5% as domestic advertising revenues were lower by 7.7% due to FTA withdrawal (Zee Anmol) and challenging macroeconomic environment. EBITDA fell 26.3% YoY to Rs 297.3 crore for the quarter.



Glenmark Pharmaceuticals 

The pharma company reported a 1.1 percent year-on-year growth in profit at Rs 260.4 crore for the quarter ended September FY23, with revenue rising 7.2% YoY to Rs 3,375.2 crore for the quarter impacted by North America business that fell 0.1% YoY but India business grew by 12.7% and Europe 11.9% YoY. EBITDA increased by 5.3% to Rs 621.6 crore in Q2FY23 and margin declined by 40 bps to 18.4% compared to year-ago period. Numbers were ahead of analysts' estimates.



Bharat Dynamics

The state-owned company reported a massive 75.3% year-on-year growth in profit at Rs 75.8 crore for the quarter ended September FY23 supported by healthy operating performance and higher other income. Revenue grew by 6.1% to Rs 534.8 crore compared to year-ago period. EBITDA increased by 41.9% YoY to Rs 93.8 crore and margin expanded by 450 bps YoY to 17.6% for the quarter.



Fortis Healthcare 

The healthcare services provider has registered a massive 67% year-on-year increase in consolidated profit at Rs 218.24 crore for the quarter ended September FY23, driven by exceptional gain, higher other income and lower tax cost. Consolidated revenue rose by 9.9% to Rs 1,607 crore and EBITDA increased 6.5% to Rs 302.9 crore compared to same period last year.

Share Market News 

ABB India 

The company clocked a massive 68.6% year-on-year growth in profit at Rs 202.5 crore for the quarter ended September FY23 with revenue rising 19.2% YoY to Rs 2,119.7 crore. The strong performance for the quarter can be attributed to its expanding customer base and industry-leading product portfolio. On the operating front, EBITDA increased by 16.4% YoY to Rs 211 crore and margin expanded by 50 bps YoY to 10% for the quarter.



Thermax 

The energy and environment solutions company recorded a 24.1% year-on-year growth in profit at Rs 109.2 crore for the quarter ended September FY23 on strong top line and operating performance. Revenue grew by 41.3% to Rs 2,075.3 crore and EBITDA surged 28.4% to Rs 140.8 crore for the quarter compared to same period last year. As on September 2022, Thermax Group had an order balance of Rs 9,485 crore, up 46% YoY.



Info Edge India 

The internet company has registered 42.4% quarter-on-quarter decline in profit at Rs 103 crore for the quarter ended September FY23 impacted by lower other income and lower operating margin. Revenue grew by 10.4% QoQ to Rs 604.1 crore.



Sun TV Networks 

The television broadcaster clocked a 3% year-on-year growth in consolidated profit at Rs 407.4 crore on better margin performance but impacted by tepid top line growth. Consolidated revenue from operations for the quarter fell 2.7% YoY to Rs 825.7 crore and EBITDA increased by 1.7% to Rs 537.5 crore. EBITDA margin expanded to 65.1% from 62.3% on year-on-year basis.



Astral 

The CPVC pipes and fitting manufacturer has recorded a 48% year-on-year decline in consolidated profit at Rs 74.6 crore for the quarter ended September FY23 impacted by lower top line and weak operating performance. Revenue for the quarter declined 2.4% to Rs 1,171.6 crore and EBITDA fell 35.6% to Rs 144 crore compared to year-ago period



AstraZeneca Pharma 

The pharma company has clocked a 174% year-on-year increase in profit at Rs 32.6 crore for quarter ended September FY23 led by healthy operating performance. Revenue from operations at Rs 236.1 crore for the quarter grew by 19.4%, and EBITDA surged 127% YoY to Rs 40.7 crore with margin expanding by 8 percentage points.



GlaxoSmithklinr Pharmaceuticals 

The company has reported a 2.2% year-on-year increase in consolidated profit at Rs 193.4 crore for quarter ended September FY23 on good operating performance, but revenue fell 1.8% to Rs 917 crore compared to corresponding period last fiscal. EBITDA increased 0.3% YoY to Rs 256.9 crore and margin expanded 60 bps to 28% for the quarter.



Krishna Institute Of Medical Sciences 

The Telangana and Andhra Pradesh-based medical and healthcare services provider reported a 26% year-on-year growth in consolidated profit at Rs 106 crore for quarter ended September FY23 led by healthy top line. Revenue from operations at Rs 564 crore increased by 37% compared to year-ago period. EBITDA grew by 18.4% to Rs 152.5 crore and margin declined 430 bps to 27% compared to corresponding period last fiscal.

Post a Comment

0 Comments